SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 26th, 2019 • Jaguar Health, Inc. • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), is dated as of December 20, 2019, by and among Jaguar Health, Inc., a Delaware corporation (the “Company”), and the purchasers listed on the Schedule of Purchasers attached hereto (each, a “Purchaser” and collectively, the “Purchasers”).
EXCHANGE AGREEMENTExchange Agreement • December 26th, 2019 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
THIS EXCHANGE AGREEMENT (this “Agreement”) is executed as of December 23, 2019 by and between Jaguar Health, Inc., a Delaware corporation (the “Company”), and Oasis Capital, LLC, a Puerto Rico limited liability company (“Holder”).
FORM OF COMMON STOCK PURCHASE WARRANT JAGUAR HEALTH, INC.Common Stock Purchase Warrant • December 26th, 2019 • Jaguar Health, Inc. • Pharmaceutical preparations • California
THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the period (the “Exercise Period”) commencing on the date that is six (6) months after the Issuance Date and ending on 11:59 p.m., New York City time, on the Expiration Date (as defined below) but not thereafter, to subscribe for and purchase from Jaguar Health, Inc., a Delaware corporation (the “Company”), up to ( ) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant (including any Warrants to purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”) is one of the Warrants to purchase Common Stock (the “SPA Warrants”) issued pursuant to Section 1 of t
ContractLock-Up Agreement • December 26th, 2019 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
THIS LOCK-UP AGREEMENT (this “Agreement”) is made as of December 23, 2019 by and between (i) Jaguar Health, Inc., a Delaware corporation (the “Company”), and (ii) the person listed on the signature page hereto (the “Restricted Holder”). Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Exchange Agreement (as defined below).
